Background:The aim of this study was to evaluate the impact of additional coronary revascularization on the early results in patients submitted to valve surgery. Patients and Methods: A retrospective review of the cardiac surgical database between January 2000 and December 2018 was performed. A total of 1667 patients were included and divided into two groups: Group A isolated valve surgery (IVS n = 1608) and Group B with valve surgery combined to coronary artery bypass grafting (VS + CABG n = 59). Demographic, operative data and postoperative outcomes were compared between groups. Results: Patients with combined procedure were older than patients who underwent isolated valvular surgery (64.9 ± 9.2 years vs 44.4 ± 13.1 years; p = 0.0001) and there was a higher proportion of diabetics (40.7% vs 6.6%; p = 0.0001). The 30 days mortality rate in the combined procedure group was 18.6% versus 6.2% in isolated valve surgery (p = 0.001). Also post-operative complications were more frequent than for patients who underwent IVS. Additionally we noted a high prevalence of coronary artery risk factors in patients with combined procedures. Conclusion: Surgical mortality and morbidity of coexisting coronary and heart valve disease were substantially higher than IVS. More efforts in medical management may reduce the incidence of adverse outcomes.
References
[1]
Tarasoutchi, F., Montera, M.W., Grinberg, M., Barbosa, M.R., Pineiro, D.J., Sanchez, C.R., et al. (2011) Brazilian Valve Disease Directive-SBC 2011/Inter-American Valve Disease Directive—SIAC 2011. Diretriz Brasileira de Valvopatias SBC 2011/Diretriz lnteramericana de Valvopatias-SIAC 2011. Arquivos Brasileiros de Cardiologia, 97, 1-67. https://doi.org/10.1590/S0066-782X2011002000001
[2]
Folkmann, S., Gorlitzer, M., Weiss, G., Harrer, M., Thalmann, M., Poslussny, P., et al. (2010) Quality of Life in Octogenarians One Year after Aortic Valve Replacement with or without Coronary Artery Bypass Surgery. Interactive CardioVascular and Thoracic Surgery, 11, 750-753. https://doi.org/10.1510/icvts.2010.240085
[3]
Thourani, V.H., Weintraub, W.S., Craver, J.M., Jones, E.L., Mahoney, E.M. and Guyton, R.A. (2000) Ten-Year Trends in Heart Valve Replacement Operations. The Annals of Thoracic Surgery, 70, 448-455.
https://doi.org/10.1016/S0003-4975(00)01443-0
[4]
Davarpasand, T., Hosseinsabet, A. and Jalali, A. (2015) Concomitant Coronary Artery Bypass Graft and Aortic and Mitral Valve Replacement for Rheumatic Heart Disease: Short- and Mid-Term Outcomes. Interactive CardioVascular and Thoracic Surgery, 21, 322–328. https://doi.org/10.1093/icvts/ivv132
[5]
De Waard, G.A., Jansen, E.K., De Mulder, M., Vonk, A.B. and Umans, V.A. (2012) Long-Term Outcomes of Isolated Aortic Valve Replacement and Concomitant AVR and Coronary Artery Bypass Grafting. Netherlands Heart Journal, 20, 110-117.
https://doi.org/10.1007/s12471-011-0238-6
[6]
Roberts, W.C., Roberts, C.C., Vowels, T.J., et al. (2012) Effect of Coronary Bypass and Valve Structure on Outcome in Isolated Valve Replacement for Aortic Stenosis. American Journal of Cardiology, 109, 1334-1340.
https://doi.org/10.1016/j.amjcard.2011.12.028
[7]
Mullany, C.J., Elveback, L.R., Frye, R.L., Pluth, J.R., Edwards, W.D., Orszulak, T.A., et al. (1987) Coronary Artery Disease and Its Management: Influence on Survival in Patients Undergoing Aortic Valve Replacement. Journal of the American College of Cardiology, 10, 66-72. https://doi.org/10.1016/S0735-1097(87)80161-4
[8]
Florath, L., Albert, A., Hassanein, W., Arnrich, B., Rosendahl, U., Ennker, L.C., et al. (2006) Current Determinants of 30 Days and 3 Month Mortality in over 2000 Aortic Valve Replacements, Impact of Routine Laboratory Parameters. European Journal of Cardio-Thoracic Surgery, 30, 716-721.
https://doi.org/10.1016/j.ejcts.2006.08.009
[9]
Kaul, K.T., Al Khadimi, R., Sharif, H. and Ramsdale, D.R. (1989) Results of Combined Valve Replacement and Myocardial Revascularization. Relation to Method of Myocardial Protection. The Journal of Cardiovascular Surgery, 30, 322-327.
[10]
Fihn, S.D., Blankenship, J.C., Alexander, K.P., et al. (2014) ACC/AHA/AATS/ PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients with Stable Ischemic Heart Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 64, 1929-1949. https://doi.org/10.1016/j.jacc.2014.07.017
[11]
Kobayashi, K.J., Williams, J.A., Nwakanna, L.U., et al. (2009) EuroSCORE Predict Short and Mid Term Mortality in Combined Aortic Valve Replacement and Coronary Artery Bypass Patients. Journal of Cardiac Surgery, 24, 637-643.
https://doi.org/10.1111/j.1540-8191.2009.00906.x
[12]
Taylor Jr., H.A., Clark, B.L., Garrison, R.J., et al. (2005) Relation of Aortic Valve Sclerosis to Risk of Coronary Heart Disease in African-Americans. American Journal of Cardiology, 95, 401-404. https://doi.org/10.1016/j.amjcard.2004.09.043
[13]
Li, Z., Anderson, I., Amsterdam, E.A., Young, J.N., Parker, J. and Armstrong, E.J. (2013) Effect of Coronary Artery Disease Extent on Contemporary Outcomes of Combined Aortic Valve Replacement and Coronary Artery Bypass Graft Surgery. The Annals of Thoracic Surgery, 96, 2075-2082.
https://doi.org/10.1016/j.athoracsur.2013.07.035
[14]
Yelazquez, R.J., Lee, K.L., Deja, M.A., et al. (2011) Coronary Artery Bypass Surgery in Patients with Left Ventricular Dysfunction. The New England Journal of Medicinec, 364, 1607-1616. https://doi.org/10.1056/NEJMoa1100356
[15]
DiSesa, C.J., Cohn, L.H., Collins Jr., J.J., Koster Jr., J.K. and VanDevanter, S. (1982) Determinants of Operative Survival Following Combined Mitral Valve Replacement and Coronary Revascularization. The Annals of Thoracic Surgery, 34, 482-489.
https://doi.org/10.1016/S0003-4975(10)62992-X
[16]
He, G.W., Hughes, C.F., McCaughan, B., Thomson, D.S., Leckie, B.D., Yang, C.Q., et al. (1991) Mitral Valve Replacement Combined with Coronary Artery Operation: Determinants of Early and Late Results. The Annals of Thoracic Surgery, 51, 916-923.
https://doi.org/10.1016/0003-4975(91)91005-G
[17]
Suleiman, M.S., Hancock, M., Shukla, R., Rajakaruna, C. and Angelini, G.D. (2011) Cardioplegic Strategy to Protect the Hypertrophic Heart during Cardiac Surgery. Perfusion, 26, 48-56. https://doi.org/10.1177/0267659111420607
[18]
Gunay, R., Sensoz, Y., Kayacioglul, I., Tuygun, A.K., Balci, A.Y., Kisa, U., et al. (2009) ls the Aortic Valve Pathology Type Different for Early and Late Mortality in Concomitant Aortic Valve Replacement and Coronary Artery Bypass Surgery? Interactive CardioVascular and Thoracic Surgery, 9, 630-634.
https://doi.org/10.1510/icvts.2009.206078
[19]
Biancari, F., Martin, M., Bordin, G., Vettore, E., Vinco, G., Anttila, V., Airaksinen, J. and Vasques, F. (2014) Basic Data from 176 Studies on the Immediate Outcome after Aortic Valve Replacement with or without Coronary Artery Bypass Surgery. Journal of Cardiothoracic and Vascular Anesthesia, 28, 1251-1256.
https://doi.org/10.1053/j.jvca.2013.07.020
[20]
Sakakura, R., Asai, T., Suzuki, T., Kinoshita, T., Enomoto, M., Kondo, Y. and Shiraishi, S. (2019) Outcomes after Aortic Valve Replacement for Aortic Valve Stenosis, with or without Concomitant Coronary Artery Bypass Grafting. General Thoracic and Cardiovascular Surgery, 67, 510-517.
https://doi.org/10.1007/s11748-018-1053-4
[21]
Vasques, F., Lucenteforte, E., Paone, R., Mugelli, A. and Biancari, F. (2012) Outcome of Patients Aged ≥80 Years Undergoing Combined Aortic Valve Replacement and Coronary Artery Bypass Grafting: A Systematic Review and Meta-Analysis of 40 Studies. American Heart Journal, 164, 410-418.
https://doi.org/10.1016/j.ahj.2012.06.019
[22]
Lacy, J., Goodin, R., McMartin, D., Masden, R. and Flowers, N. (1970) Coronary Atherosclerosis in Valvular Heart Disease. The Annals of Thoracic Surgery, 23, 429-435.
https://doi.org/10.1016/S0003-4975(10)64162-8
[23]
Sonmez, K., Gencbay, M., Akcay, A., et al. (2002) Prevalence and Predictors of Significant Coronary Artery Disease in Turkish Patients Who Undergo Heart Valve Surgery. The Journal of Heart Valve Disease, 11, 431-437.
[24]
Nogo, D.T.M., Sverdlov, A.L., Willoughby, S.R., et al. (2009) Determinants of Occurrence of Aortic Sclerosis in an Aging Population. JACC: Cardiovascular lmaging, 2, 919-927. https://doi.org/10.1016/j.jcmg.2009.03.016
[25]
Perez, S., Thielhelm, T.P. and Cohen, M.G. (2018) To Revascularize or Not before Transcatheter Aortic Valve Implantation? Journal of Thoracic Disease, 10, S3578- S3587. https://doi.org/10.21037/jtd.2018.09.85
[26]
Jose, V.J., Gupata, S.N., Joseph, G., et al. (2004) Prevalence of Coronary Artery Disease in Patients with Rheumatic Heart Disease in the Current Era. Indian Heart Journal, 56, 129-131.
[27]
Kruczan, D.D., Silva, N.A., Pereira, B.B., Romao, V.A., Correa Filho, W.B. and Morales, F.E. (2008) Coronary Artery Disease in Patients with Rheumatic and Non rheumatic Valvular Heart Disease Treated at A Public Hospital in Rio de Janeiro. Arquivos Brasileiros de Cardiologia, 90, 197-203.
https://doi.org/10.1590/S0066-782X2008000300010
[28]
Junior, O., de Lima, J., et al. (2009) Does the Coronary Disease Increase the Hospital Mortality in Patients with Aortic Stenosis Undergoing Valve Replacement? Revista Brasileira de Cirurgia Cardiovascular, 24, 453-462.
[29]
Di Gioia, G., Pellicano, M., Toth, G.G., Casselman, F., Adjedj, J., Van Praet, F., Ferrara, A., Stockman, B., Degrieck, I., Bartunek, J., Trimarco, B., Wijns, W., De Bruyne, B. and Barbato, E. (2016) Fractional Flow Reserve-Guided Revascularization in Patients with Aortic Stenosis. American Journal of Cardiology, 117, 1511-1515.
https://doi.org/10.1016/j.amjcard.2016.02.023
[30]
Shah, T., Geleris, J.D., Zhong, M., Swaminathan, R.V., Kim, L.K. and Feldman, D.N. (2017) Fractional Flow Reserve to Guide Surgical Coronary Revascularization. Journal of Thoracic Disease, 9, S317-S326. https://doi.org/10.21037/jtd.2017.03.55
[31]
Emren, Z.Y., Emren, S.V., Kilicaslan, B., Solmaz, H., Susam, I., Sayin, A., et al. (2014) Evaluation of the Prevalence of Coronary Artery Disease in Patients with Valvular Heart Disease. Journal of Cardiothoracic Surgery, 9, 153.
https://doi.org/10.1186/s13019-014-0153-1
[32]
Jian, B., Narula, N., Li, Q.Y., Mohler, E.R. and Levy, R.J. (2003) Progression of Aortic Valve Stenosis: TGF-β1 Is Present in Calcified Aortic Valve Cusps and Promotes Aortic Valve Interstitial Cell Calcification via Apoptosis. The Annals of Thoracic Surgery, 75, 457-465. https://doi.org/10.1016/S0003-4975(02)04312-6
[33]
Rajamannan, N.M., Gersh, B. and Bonow, R.O. (2003) Calcific Aortic Stenosis: From Bench to the Bedside-Emerging Clinical and Cellular Concepts. Heart, 89, 801-805. https://doi.org/10.1136/heart.89.7.801
[34]
Olsen, M.H., Wachtell, K., Bella, J.N., Gerdts, E., Palmieri, V., Niemien, M.S., Smith, G., lbsen, H. and Devereux, R.B. (2005) LIFE Substudy. Aortic Valve Sclerosis Relates to Cardiovascular Events in Patients with Hypertension (a LIFE Substudy). American Journal of Cardiology, 95, 132-136.
https://doi.org/10.1016/j.amjcard.2004.08.080
[35]
Rajamannan, N.M. and Otto, C.M. (2004) Targeted Therapy to Prevent Progression of Calcific Aortic Stenosis. Circulation, 110, 1180-1182.
https://doi.org/10.1161/01.CIR.0000140722.85490.EA
